Advertisement

Topics

Myriad Genetics Company Profile

10:56 EDT 26th September 2017 | BioPortfolio

Myriad Genetics, Inc. is a leader in the discovery of major common human disease genes and their related pathways. TheCompany utilizes analyses of extensive family histories and genetic material, as well as a number of proprietary technologies, to identify inherited gene mutations which increase the risk to individuals of developing these diseases.

The Company has also developed ProNet(TM), a proprietary high-throughput assay to identify protein-protein interactions. The Company believes that the application of these technologies may provide new insights into protein function and cellular organization which may lead to the identification of novel therapeutic targets. The discovery of disease-predisposing genes and their biochemical pathways provides the Company with three significant commercial opportunities: (i) the development and marketing of genetic testing and information services, such as its BRACAnalysis(TM) test and its recently launched CardiaRisk(TM) test, for the identification of individuals who are genetically predisposed to developing a particular disease, (ii) the marketing of subscriptions to the ProNet(TM) database of protein interactions, and (iii) the development of therapeutic products for the treatment and prevention of major diseases associated with these genes and their biochemical pathways.

Location

320 Wakara Way
Salt Lake City
UT
84108
United States of America

Contact

Phone: 801 584 3600
Fax: 801 584 3640
Email: investor@myriad.com


News Articles [729 Associated News Articles listed on BioPortfolio]

$0.21 Earnings Per Share Expected for Myriad Genetics, Inc. (MYGN) This Quarter

Wall Street brokerages forecast that Myriad Genetics, Inc. will post earnings of $0.21 per share for the current quarter, Zacks reports. Five analysts have made estimates for Myriad Genetics' earn...

Myriad Genetics Inc. Q4 Earnings Decline 21%

WASHINGTON (dpa-AFX) - Myriad Genetics Inc. (MYGN) released a profit for fourth quarter that dropped from last year.The company said its earnings fell to $20.8 million, or $0.30 per share. This wa...

Myriad Genetics, Inc. (MYGN) Raised to "Hold" at BidAskClub

Other analysts also recently issued reports about the stock. TheStreet upgraded shares of Myriad Genetics from a "d+" rating to a "c" rating in a research report on Wednesday, March 1st.

Myriad Genetics, Inc. (MYGN) Sets New 12-Month High at $33.08

Myriad Genetics, Inc. 's share price hit a new 52-week high during trading on Wednesday . The stock traded as high as $33.08 and last traded at $33.04, with a volume of 1,166,494 shares changing h...

Reviewing Myriad Genetics

Myriad Genetics and Cepheid are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, divide...

Myriad Genetics Announces Results from a Large 2,000 Patient Clinical ...

Myriad Genetics , Inc. , a leader in molecular diagnostics and personalized medicine, today announced results from Study 005, a large 2,000 patient prospective study of the Myriad myRiskA Hereditary C...

Myriad Genetics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 13062017] Prices from USD $350

Myriad Genetics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Myriad Genetics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment...

Palmetto, Anthem to cover use of Myriad's breast cancer recurrence test

Myriad Genetics obtained positive coverage decisions from Anthem and Medicare contractor Palmetto GBA for its EndoPredict bre -More- 

Drugs and Medications [0 Results]

None

PubMed Articles [761 Associated PubMed Articles listed on BioPortfolio]

The Clinic Is My Laboratory: Life as a Clinical Geneticist.

Clinical genetics is the application of advances in genetics and medicine to real human families. It involves diagnosis, care, and counseling concerning options available to affected individuals and t...

Introduction to behavioral phenotypes in medical genetics.

25 more years.

This month, to celebrate a quarter century of excellence in genetics, we are highlighting selections from the past work we have published. We will then publish a number of forward-looking Perspectives...

Ocular genetics in Taiwan.

Ocular genetics is an emerging specialty which has accompanied the advancement of modern genetic technology. This review is to understand the current status of practice in ocular genetics in Taiwan.

In This Issue.

Clinical Trials [296 Associated Clinical Trials listed on BioPortfolio]

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics

This study will describe the experience of patients with visible physical abnormalities in the genetics clinic when they are involved in teaching others about their condition. Information ...

Virtual Reality Intervention in Cancer Genetics

The goal of this study is to evaluate a virtual reality-based intervention for training health care providers who are not genetics specialists to effectively communicate with and counsel p...

Genetics of Asthma and Bronchial Hyperresponsiveness

To investigate the genetics of asthma by reexamining a carefully characterized population of patients with asthma, and by studying their families.

Cultural Congruence in International Genetics Research

This study will explore how cultural differences influence genetics research in developing countries. Human genetics research is becoming more common in developing countries. However, when...

Companies [61 Associated Companies listed on BioPortfolio]

Myriad Genetics, Inc.

Myriad Genetics, Inc. is a biotechnology company focused on the development and marketing of novel therapeutic and molecular diagnostic products. Myriad's news and other information are available on t...

Myriad House

PR Week ranks Myriad as a UK top 150 PR agency and as number one in Cambridgeshire and across the East of England region. One of the country’s leading healthcare agencies, and among the largest...

AccessDNA, Inc.

AccessDNA is the leading online consumer resource for genetics. The company combines high-quality content about genetics with access to, and evaluation of, relevant testing, couns...

Ambry Genetics Corporation

Ambry Genetics is a privately held healthcare company with the industry’s most comprehensive suite of genetic testing solutions, benefiting 90% of all U.S. patients covered b...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent ce...

More Information about "Myriad Genetics" on BioPortfolio

We have published hundreds of Myriad Genetics news stories on BioPortfolio along with dozens of Myriad Genetics Clinical Trials and PubMed Articles about Myriad Genetics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Myriad Genetics Companies in our database. You can also find out about relevant Myriad Genetics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...


Corporate Database Quicklinks



Searches Linking to this Company Record